  Human lymphatic filariasis<disease> , a mosquito-borne neglected tropical parasitic<disease> disease<disease> , needs an early development of prophylactic agents such as a vaccine for its successful elimination. Our earlier study suggested the enhanced immunological response by fusion protein ( P-TUFT-ALT-2) of Tuftsin and ALT-2 in a mice model. We cultured human peripheral blood mononuclear cells ( PBMCs) and treated cells with